U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
( ) Form 10-K, ( ) Form 20-5, ( ) Form 11-K, ( X ) Form 10-Q,
( ) Form N-SAR
For Period Ended: July 31, 1998
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ____________________
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
Full Name of Registrant:
Creative Medical Development, Inc.
----------------------------------
Former Name if Applicable:
------------------------------
Address of Principal Executive Office (Street and Number):
975 SE Sandy Boulevard
----------------------
City, State and Zip Code:
Portland, Oregon 97214
----------------------
PART II - RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b) [Section
23,047], the following should be completed. (Check box if appropriate.)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense.
(b) The subject annual report or semi-annual report/portion thereof will
be filed on or before the fifteenth calendar day following the
[X] prescribed due date; or the subject quarterly report/portion thereof
will be filed on or before the fifth [ X ] calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
<PAGE>
PART III - NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q or N-SAR or portion thereof could not be filed within the prescribed time
period.
Registrant is not yet able to close its quarterly records.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
M. Charles Van Rossen (503) 230-8034
--------------------- ----- --------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[ X ] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [ X ] No
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Creative Medical Development, Inc.
----------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: September 11, 1998 By /s/ M. Charles Van Rossen
----------------------------------
M. Charles Van Rossen, CFO
